High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial
高剂量奥莫替尼治疗未经治疗的EGFR变异型非小细胞肺癌伴脑转移：ACHIEVE II期非随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.1779
Li, Hui; Chen, Kaiyan; Gong, Lei; Qin, Jing; Jin, Ying; Zhou, Rongrong; Huang, Zhiyu; Xu, Yanjun; Xu, Xiaoling; He, Jingdong; Zhu, Junfei; Yu, Sizhe; Lu, Hongyang; Xu, Yujin; Yu, Xinmin; Han, Guang; Chen, Jun; Tan, Wei; Lou, Guangyuan; Ren, Biyong; Chen, Xiangqi; Zhang, Dianbao; Wang, Wenxian; Shi, Xun; Xie, Fajun; Zhao, Jun; Han, Na; Li, Bing; Fan, Yun
